Interventional Mental Health: A Transdisciplinary Approach to Novel Psychiatric Care Delivery.
Jonathann Kuo, Tabitha Block, Megan Nicklay, Brandon Lau, Marcel Green
Cureus August 1, 2023 DOI: 10.7759/cureus.43533 via PubMed
Summary
AI-generated from the abstractMental health disorders are common in the United States, and standard treatments rely on counseling and medication. A new model called Interventional Mental Health combines multiple modalities—Stellate Ganglion Blocks, Transcranial Magnetic Stimulation, and ketamine therapy—into a single treatment algorithm. The authors hypothesize that delivering these therapies together within a consolidated timeframe will produce synergistic benefits for patients with comorbid PTSD, depression, and anxiety who have not responded well to traditional methods.
Study at a glance
| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Interventions | Stellate Ganglion Blocks Transcranial Magnetic Stimulation ketamine therapy |
| Topics | Depression |
| Keywords | Autonomic dysregulation Iv ketamine infusion Treatment of depression |
| Citations | 2 |
| Key finding | Combining Stellate Ganglion Blocks, Transcranial Magnetic Stimulation, and ketamine therapy in a consolidated treatment algorithm may produce synergistic outcomes for patients with comorbid PTSD, depression, and anxiety. |
Abstract
Mental health disorders are among the most common health conditions in the United States. Traditional clinical treatments rely on psychiatric counseling and, in many cases, prescription medications. We propose an innovative model, Interventional Mental Health, which employs a combination of modalities through a multifaceted approach to treat conditions that have exhibited limited responsiveness to traditional methods and individuals afflicted with multiple comorbidities simultaneously. We hypothesize that creating a unique treatment algorithm combining current therapeutic modalities such as Stellate Ganglion Blocks (SGB), Transcranial Magnetic Stimulation (TMS) therapy, and ketamine therapy, within a consolidated timeframe, will yield synergistic outcomes among patients presenting with comorbid post-traumatic stress disorder (PTSD), depression, and/or anxiety.